Alligator Bioscience and Scandion Oncology have announced the conclusion of their collaboration with a very positive outcome.
The purpose of the collaboration was to explore the anti-tumor efficacy of the CD40 antibody mitazalimab in chemotherapy-resistant preclinical tumor models as an addition